Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors.

Journal of Experimental & Clinical Cancer Research : CR
Sean CaenepeelPaul E Hughes

Abstract

Activating mutations in Kit receptor tyrosine kinase or the related platelet-derived growth factor receptor (PDGFR) play an important role in the pathogenesis of gastrointestinal stromal tumors (GIST). This study investigated the activity of motesanib, an inhibitor of vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3; PDGFR; and Kit, against primary activating Kit mutants and mutants associated with secondary resistance to imatinib. Single- and double-mutant isoforms of Kit were evaluated for their sensitivity to motesanib or imatinib in autophosphorylation assays and in Ba/F3 cell proliferation assays. Motesanib inhibited Kit autophosphorylation in CHO cell lines expressing primary activating mutations in exon 9 (AYins503-504, IC50 = 18 nM) and exon 11 (V560 D, IC50 = 5 nM; Delta552-559, IC50 = 1 nM). Motesanib also demonstrated activity against kinase domain mutations conferring imatinib resistance (V560D/V654A, IC50 = 77 nM; V560D/T670I, IC50 = 277 nM; Y823 D, IC50 = 64 nM) but failed to inhibit the imatinib-resistant D816V mutant (IC50 > 3000 nM). Motesanib suppressed the proliferation of Ba/F3 cells expressing Kit mutants with IC50 values in good agreement with those observed in the autophosphorylation assay...Continue Reading

References

Mar 22, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·N V BotchkarevaB A Gilchrest
May 10, 2002·The American Journal of Pathology·Christopher L CorlessMichael C Heinrich
Aug 16, 2002·The New England Journal of Medicine·George D DemetriHeikki Joensuu
Jan 11, 2003·Science·Michael C HeinrichJonathan A Fletcher
Sep 11, 2003·The Journal of Pharmacology and Experimental Therapeutics·Katherine G MossA Douglas Laird
Dec 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael C HeinrichJonathan A Fletcher
May 5, 2004·The Journal of Biological Chemistry·Clifford D MolKeith P Wilson
Sep 15, 2004·Journal of Molecular Graphics & Modelling·Rowan FosterLeonie Ashman
Sep 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher L CorlessMichael C Heinrich
Dec 24, 2005·Molecular Cancer Therapeutics·Sean R McLeanChris Boshoff
Sep 7, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael C HeinrichJonathan A Fletcher
Mar 17, 2007·Molecular Cancer Therapeutics·Kathryn G RobertsLeonie K Ashman
Jun 15, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lee S RosenRoy S Herbst
Jul 4, 2008·The New England Journal of Medicine·Steven I ShermanUNKNOWN Motesanib Thyroid Cancer Study Group
Jan 2, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Angela CoxonAnthony Polverino
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ketan S GajiwalaGeorge D Demetri
Jul 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin J SchlumbergerSteven I Sherman

❮ Previous
Next ❯

Citations

Jan 22, 2011·Trends in Molecular Medicine·Andrea MorandiClare M Isacke
Nov 10, 2011·Journal of Surgical Oncology·Edward J Kim, Mark M Zalupski
Nov 15, 2014·Future Oncology·Maristella SaponaraGuido Biasco
May 5, 2011·Critical Reviews in Biochemistry and Molecular Biology·Jonathan P DiNitto, Joe C Wu

❮ Previous
Next ❯

Methods Mentioned

BETA
Transfection
Assay
xenograft

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.